Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Ludwig

Showing results (91-100 of 231) with videos related to

Pageof 24
Sort By:
Biological Chemistry|November 5, 2011
The influenza virus PB1-F2 protein has interferon antagonistic activitySabine E Dudek, Ludmilla Wixler, Carolin Nordhoff, et al.
Pharmaceutics|September 28, 2021
Combination Therapy with Fluoxetine and the Nucleoside Analog GS-441524 Exerts Synergistic Antiviral Effects against Different SARS-CoV-2 Variants In VitroLinda Brunotte, Shuyu Zheng, Angeles Mecate-Zambrano, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 21, 2010
MAP kinase-activated protein kinases 2 and 3 are required for influenza A virus propagation and act via inhibition of PKRChristina Luig, Katharina Köther, Sabine Eva Dudek, et al.
Virology Journal|May 25, 2026
The activation of the metabolic oxaloacetate-pyruvate axis restores influenza A virus replication during impaired glycolysisChiara Robin Bojarzyn, Nadine Bieß, Matthias Behrens, et al.
British Journal of Pharmacology|April 7, 2021
Drug synergy of combinatory treatment with remdesivir and the repurposed drugs fluoxetine and itraconazole effectively impairs SARS-CoV-2 infection in vitroSebastian Schloer, Linda Brunotte, Angeles Mecate-Zambrano, et al.
The American Journal of Pathology|February 20, 2018
The Four-and-a-Half LIM Domain Protein 2 Supports Influenza A Virus-Induced Lung Inflammation by Restricting the Host Adaptive Immune ResponseDörthe Masemann, Rafael Leite Dantas, Siarhei Sitnik, et al.
The Biochemical Journal|May 22, 2002
Hypoxia/reoxygenation induction of monocyte chemoattractant protein-1 in melanoma cells: involvement of nuclear factor-kappaB, stimulatory protein-1 transcription factors and mitogen-activated protein kinase pathwaysManfred Kunz, Gisela Bloss, Reinhard Gillitzer, et al.
The EMBO Journal|May 30, 2003
Caspase 3 activation is essential for efficient influenza virus propagationWalter J Wurzer, Oliver Planz, Christina Ehrhardt, et al.
FEBS Letters|March 12, 2004
MEK inhibition impairs influenza B virus propagation without emergence of resistant variantsStephan Ludwig, Thorsten Wolff, Christina Ehrhardt, et al.
Retrovirology|April 18, 2009
High level expression of the anti-retroviral protein APOBEC3G is induced by influenza A virus but does not confer antiviral activityEva-K Pauli, Mirco Schmolke, Henning Hofmann, et al.
Pageof 24

Showing results (91-100 of 231) with videos related to

Sort By:
Pageof 24
Biological Chemistry|November 5, 2011
The influenza virus PB1-F2 protein has interferon antagonistic activitySabine E Dudek, Ludmilla Wixler, Carolin Nordhoff, et al.
Pharmaceutics|September 28, 2021
Combination Therapy with Fluoxetine and the Nucleoside Analog GS-441524 Exerts Synergistic Antiviral Effects against Different SARS-CoV-2 Variants In VitroLinda Brunotte, Shuyu Zheng, Angeles Mecate-Zambrano, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 21, 2010
MAP kinase-activated protein kinases 2 and 3 are required for influenza A virus propagation and act via inhibition of PKRChristina Luig, Katharina Köther, Sabine Eva Dudek, et al.
Virology Journal|May 25, 2026
The activation of the metabolic oxaloacetate-pyruvate axis restores influenza A virus replication during impaired glycolysisChiara Robin Bojarzyn, Nadine Bieß, Matthias Behrens, et al.
British Journal of Pharmacology|April 7, 2021
Drug synergy of combinatory treatment with remdesivir and the repurposed drugs fluoxetine and itraconazole effectively impairs SARS-CoV-2 infection in vitroSebastian Schloer, Linda Brunotte, Angeles Mecate-Zambrano, et al.
The American Journal of Pathology|February 20, 2018
The Four-and-a-Half LIM Domain Protein 2 Supports Influenza A Virus-Induced Lung Inflammation by Restricting the Host Adaptive Immune ResponseDörthe Masemann, Rafael Leite Dantas, Siarhei Sitnik, et al.
The Biochemical Journal|May 22, 2002
Hypoxia/reoxygenation induction of monocyte chemoattractant protein-1 in melanoma cells: involvement of nuclear factor-kappaB, stimulatory protein-1 transcription factors and mitogen-activated protein kinase pathwaysManfred Kunz, Gisela Bloss, Reinhard Gillitzer, et al.
The EMBO Journal|May 30, 2003
Caspase 3 activation is essential for efficient influenza virus propagationWalter J Wurzer, Oliver Planz, Christina Ehrhardt, et al.
FEBS Letters|March 12, 2004
MEK inhibition impairs influenza B virus propagation without emergence of resistant variantsStephan Ludwig, Thorsten Wolff, Christina Ehrhardt, et al.
Retrovirology|April 18, 2009
High level expression of the anti-retroviral protein APOBEC3G is induced by influenza A virus but does not confer antiviral activityEva-K Pauli, Mirco Schmolke, Henning Hofmann, et al.
Pageof 24